Charles River Laboratories International Company
Charles River Laboratories International provides research models and outsourced preclinical services for the accelerated R&D of drugs.
Technology:
Drug Delivery
Industry:
AI, Early Drug Development
Headquarters:
Wilmington, Massachusetts, United States
Founded Date:
1947-01-01
Employees Number:
5001-10000
Funding Status:
IPO
Acquisitions Number:
32
Investors Number:
1
Total Funding:
1534000000
Estimated Revenue:
$500M to $1B
Last Funding Date:
2021-03-23
Last Funding Type:
Post-IPO Debt
Register and Claim Ownership